BioMarin Pharmaceutical
BMRN
$80.91
Share price
-1.53%
Change (1 day)
-13.00%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total debt
Total debt on the balance sheet as of December 2023 : $1.09 B
According to BioMarin Pharmaceutical's latest financial reports the company's total debt is $1.09 B. A company’s total debt is the sum of all current and non-current debts.
BioMarin Pharmaceutical - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.09 B | 0.22% |
| 2022-12-31 | $1.09 B | 0.35% |
| 2021-12-31 | $1.08 B | 0.24% |
| 2020-12-31 | $1.08 B | 26.56% |
| 2019-12-31 | $0.85 B | 3.42% |
| 2018-12-31 | $0.83 B | -29.29% |
| 2017-12-31 | $1.17 B | 71.9% |
| 2016-12-31 | $0.68 B | 3.16% |
| 2015-12-31 | $0.66 B | 3.02% |
| 2014-12-31 | $0.64 B | -1.93% |
| 2013-12-31 | $0.65 B | 88.26% |
| 2012-12-31 | $0.34 B | -0.03% |
| 2011-12-31 | $0.34 B | -7.73% |
| 2010-12-31 | $0.37 B | -24.05% |
| 2009-12-31 | $0.49 B | -12.46% |
| 2008-12-31 | $0.56 B | 14.16% |
| 2007-12-31 | $0.49 B | 115.57% |
| 2006-12-31 | $0.23 B | 2.88% |
| 2005-12-31 | $0.22 B | -17.2% |
| 2004-12-31 | $0.27 B | 116.67% |
| 2003-12-31 | $0.12 B | |
| 2001-12-31 | $5.55 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $20.36 B | 1,758.74% | 🇫🇷 France |
 Ultragenyx RARE | $43.16 M | -96.06% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $38.1 M | -96.52% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.26 B | -75.71% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.44 B | -59.38% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $3.55 M | -99.68% | 🇺🇸 USA |